Skip to main content
Premium Trial:

Request an Annual Quote

Anavasi Diagnostics: Bryan Crane, Arthur Kirsch, David Vied

Anavasi Diagnostics has elected three outside members to its board of directors, Bryan Crane, Arthur Kirsch, and David Vied. Crane is currently VP, head of system design at Illumina, while Kirsch is a director at biopharmaceutical firm Liquidia. Vied is the global sector leader for the medical devices practice for Korn Ferry and also is the director of Cyanotech, which develops and markets microalgae based supplements. A spinout of the University of Washington, Anavasi focuses on developing molecular diagnostic tests using a proprietary reverse transcriptase method.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find structural network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.